Topic: Zyprexa
Eli Lilly (LLY) is one of the largest of the " Eli Lilly's near-term forecast is strong, as Cymbalta continues to gain approval for new indications, and the company focuses on expanding their overseas sales, where they lag competitors like Pfizer (PFE). ...
On May 25, 2007, Kevin Xu logged into his Gmail account and found a startling message from a man who could have been his biggest client.. Back in March, Xu and his wife, Jennifer, met Ed at the Starbucks in the Bangkok ...
LONDON (Reuters) - People with high levels of the hormone dopamine in the brain, and low sensitivity to it, tend to be greater risk takers and may be more prone to addictive behavior, drug abuse and gambling, a study has found.Scientists from ...
Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc.The Indianapolis company earned $915.4 million, or 83 cents per share, in the three months ...
Pharmaceutical company Eli Lilly and Co. says it turned a fourth-quarter profit after recording a loss in 2008 following the buyout of cancer drug maker ImClone Systems Inc. The Indianapolis company earned $915.4 million, or 83 cents per share, in the three ...
The FDA just approved a new, extended-release version of Eli Lilly's antipsychotic drug Zyprexa. The company is likely to face generic competition on regular-selling Zyprexa in 2011. Regular Zyprexa is taken every day, and is available as a pill or injection; the ...
WASHINGTON (Reuters) - U.S. drug reviewers recommended that regulators further study the effects in children of a group of medicines known as atypical antipsychotics, a report released on Friday said.Food and Drug Administration staff said a recent study of health insurance claims ...
The FDA today approved the use of two antipsychotic drugs - Eli Lilly's Zyprexa and AstraZeneca's Seroquel - in teenagers. An FDA advisory panel on pediatric drugs meeting next week will discuss the issue; a report written by FDA staff and released ...
CHICAGO (Reuters) - Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said on ...
SC AG reaches $45M deal with drug maker Eli Lilly over anti-psychotic drugSouth Carolina's attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly & "This is a victory for South Carolina's taxpayers who were ...